Drugmakers Bristol-Myers Squibb Company, AstraZeneca PLC, And Sanofi-Aventis (France) Post Improved 1st-Quarter Profits And Sales, Rest Of Year Looks Less Rosy

April 30, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

AP -- TRENTON, N.J. — Three top drugmakers on Thursday posted healthy increases in first-quarter sales and profits, with strong sales of key drugs buoying Bristol-Myers Squibb Co., AstraZeneca LP and Sanofi-Aventis SA.

Twitter
LinkedIn
Facebook
Email
Print

Earnings

AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Company Sanofi (France)